Brain Submission Process

The process usually feels cleaner when the manuscript already arrives with:

• a broad-enough neurology audience case
• a mechanistic or disease-biology consequence that is visible early
• methods and supplement stable enough for a hard editorial read
• a cover letter that explains why this belongs in Brain specifically

If those pieces are soft, the workflow can feel harsher than authors expect because the system exposes weakness early.

The first stage is not mainly testing technical compliance.

It is testing whether:

• the paper belongs in Brain rather than a narrower neurology or neuroscience journal
• the mechanistic and neurological consequence is strong enough to justify reviewer time
• the evidence package supports the breadth of the claim
• the manuscript looks complete enough for serious evaluation

That is why fast rejection here often means "not broad or mechanistic enough for this journal," not "bad science."

Authors should think in stages:

• the earliest period is mostly fit, mechanism, and package-stability judgment
• movement into fuller review usually means the hardest editorial screen has been cleared
• later slowdowns often reflect reviewer alignment or evidentiary questions rather than admin delay

The practical point is that the real risk sits early. Once the paper survives that first triage read, the process becomes more about how well the evidence carries the mechanistic claim.

Brain follows standard OUP/ScholarOne submission requirements:

• manuscript file (Word preferred) with embedded figures
• separate high-resolution figure files
• cover letter
• supplementary material as separate files
• conflict of interest disclosures
• patient consent documentation (mandatory for case studies)
• data availability statement

What's specific to Brain:

Word limits are strict. Original Articles are limited to 5,000 words (excluding abstract, references, tables, and figure legends). Reviews can be longer with editorial approval. These limits are tighter than many neuroscience journals.

Structured abstracts are required. The format is Background, Methods, Results, and Discussion (not Conclusions). This differs from most medical journals that use Background/Methods/Results/Conclusions.

Patient consent is taken seriously. Any case report, case series, or study using identifiable patient data requires explicit consent documentation. Brain will ask for this during review if it's not provided upfront.

Before you upload, running through Brain submission readiness check can catch formatting gaps and strengthen the mechanistic framing.

1. Is there a mechanistic contribution, not just a clinical observation? Brain wants papers that explain disease mechanisms. A large cohort study showing that biomarker X predicts outcome Y in Parkinson's disease is descriptive. A study showing that biomarker X reflects a specific degenerative process and explaining why that process predicts outcome Y is mechanistic. Brain wants the second paper.

2. Is the neurological disease relevance front and center? Pure neuroscience papers about synaptic plasticity or neural circuitry without direct connection to neurological disease belong at Journal of Neuroscience or Neuron. Brain wants the disease angle to be obvious from the title and abstract.

3. Are the methods appropriate for the claim? Brain's academic editors are practicing researchers who know what controls and sample sizes are standard in each subfield. Underpowered imaging studies, genetic analyses without proper correction for multiple comparisons, and animal models without behavioral validation are flagged quickly.

4. Does the paper span basic and clinical neurology? The strongest Brain papers often combine clinical cohort data with experimental validation, or use patient-derived materials to test mechanistic hypotheses. Papers that sit entirely in one domain (purely clinical or purely experimental) face a higher bar.

Several things repeatedly make the process go badly:

The science may be solid, but if the manuscript mainly catalogs a phenomenon rather than explaining it, editors often see that quickly.

Brain is broad within neurology. If the natural readership is mostly one subspecialty niche, the paper starts to look like a better fit elsewhere.

If controls, sample logic, or analytical framing still look soft on the first read, editors have less reason to invest reviewer time.

If the title, abstract, and first figure do not make the consequence obvious, the editor has less reason to keep carrying the paper forward.

The strongest Brain submissions usually have a recognizable profile:

• one important neurological question
• one stable mechanistic conclusion
• one broad audience case for neurologists
• one first-read package that feels methodologically secure
• one cover letter that sounds like judgment, not branding

This is why the process is not just administrative. The package itself tells the editor whether the authors understand the journal.

One common failure mode is a letter that promises a broader or more practice-relevant paper than the manuscript actually delivers. Editors usually catch that mismatch immediately.

If the key neurological message takes too long to emerge, the editor may conclude the paper is too slow for Brain even if the science is real.

A Brain submission loses force when the title, abstract, supplement, and declarations still look provisional. Package instability often gets interpreted as scientific or strategic instability.

The abstract and cover letter should reinforce each other.

The abstract should:

• state the central finding plainly
• make the neurological consequence visible
• avoid overselling before the evidence can support the promise

The cover letter should:

• explain why neurologists should care
• clarify what changed mechanistically
• give the editor a clean reason to send the paper out

If those two pieces describe different levels of ambition, the package weakens immediately.

The final hour before a serious Brain submission should not be spent rewriting the science. It should be spent checking package consistency.

That usually means checking:

• the title, abstract, and cover letter make the same mechanistic promise
• the key figure supports the same promise the abstract is making
• ethics, disclosures, and funding language match the manuscript
• supplementary analyses do not quietly weaken the main story
• author order and affiliations are final

If those pieces still feel fluid, the submission often looks less mature than the science deserves.

In our pre-submission review work, Brain manuscripts do best when the first pass already reads like mechanistic neurology rather than a descriptive neuroscience or clinical-outcomes paper. The editor should be able to see both the disease relevance and the mechanistic consequence without relying on the cover letter to rescue the case.

The files that stall early are usually strong in one lane and weak in the other. Either the disease importance is clear but the mechanism is still thin, or the experimental biology is strong but the neurology readership case is underdeveloped. Brain's author instructions make clear that its editors are research-active translational neuroscientists, so that mismatch gets spotted quickly.

• the paper already looks broad enough for Brain
• the mechanistic case is stable enough to survive hard review
• the consequence is visible from the first read
• the package looks publication-ready

• the paper still needs obvious analytical strengthening
• the broad neurology case depends more on language than evidence
• the package is still being assembled during upload
• a narrower journal still looks like the more honest home

This is one of the fastest ways to weaken trust. The problem is not only overclaiming. It is making the first read unstable.

Editors need a reason the paper belongs in Brain. A letter that mainly says the work is exciting or high impact without explaining the audience case is usually weaker than authors think.

A submission can satisfy the portal while still looking conceptually unsettled. If the package logic still feels provisional, the process weakens before review starts.

• Brain journal page
• Brain Submission Guide
• Is Brain a Good Journal?
• Journal of Neuroscience Submission Guide